To further test the hypothesis that ASCL1 regulates chromatin accessibility of these transcription factors, we utilised publicly available PHOX2B and GATA3 ChIP-seq datasets in parental BE2C and Kelly neuroblastoma cell lines (Durbin et al., 2018). The gene discussed is ASCL1; the disease is neuroblastoma.